CN103229767A - Trifloxystrobin and bupirimate-containing sterilization composition - Google Patents
Trifloxystrobin and bupirimate-containing sterilization composition Download PDFInfo
- Publication number
- CN103229767A CN103229767A CN2013101684545A CN201310168454A CN103229767A CN 103229767 A CN103229767 A CN 103229767A CN 2013101684545 A CN2013101684545 A CN 2013101684545A CN 201310168454 A CN201310168454 A CN 201310168454A CN 103229767 A CN103229767 A CN 103229767A
- Authority
- CN
- China
- Prior art keywords
- bupirimate
- bacterium ester
- oxime bacterium
- trifloxystrobin
- bactericidal composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention relates to a trifloxystrobin and bupirimate-containing sterilization composition. The trifloxystrobin and bupirimate-containing sterilization composition is compounded by the active ingredients: trifloxystrobin and bupirimate in a binary compounding manner, wherein the mass ratio of the trifloxystrobin to bupirimate is (1-40):(40-1), the mass parts ratio of trifloxystrobin to bupirimate in preparation is 1%-80%, and the rest ingredients include auxiliary compositions allowable and acceptable in the pesticides. The forms of the sterilization composition comprise emulsifiable solution, suspending agent, wettable powder, water dispersible granules, emulsion in water, microemulsion, granules and microcapsules. The sterilization composition has good activity on almost all eumycetes (ascomycetes, basidiomycetes, oomycetes and fungi imperfecti) diseases such as powdery mildew, rust disease, sheath blight disease, net blotch, downy mildew, rice blast and the like, as well as good activity on damping off and apple scab.
Description
Technical field
The present invention relates to the agriculture chemical compounding technical field, particularly relate to a kind of bactericidal composition that contains oxime bacterium ester and bupirimate.
Background technology
Oxime bacterium ester is new fungicides.Characteristics such as thering is efficient, wide spectrum, protection, treat, root out, infiltration, systemic activity, resistance of rainwater washing against, lasting period are long, with at present existing bactericide without cross resistance.Nearly all Mycophytes (Ascomycetes, Basidiomycetes, Oomycete and Fungi Imperfecti) disease is all had to good activity as powdery mildew, rust, Ying's rot, net blotch, downy mildew, rice blast etc.Except powdery mildew, leaf spot are had special efficacy, rust, downy mildew, damping off, apple apple scab are had to good activity.The chemistry of oxime bacterium ester is by name: (2Z)-2-methoxyimino-2-[2-[[1-[3-(trifluoromethyl) phenyl] ethyleneimino] the oxygen methyl] phenyl] methyl acetate, its chemical structural formula is
.
Bupirimate belongs to the miazines systemic fungicide, has protection and therapeutic action.Can be absorbed rapidly by plant roots, stem, leaf, and run to each position in plant corpus, therefore resistance of rainwater washing against.Have that consumption is few, efficient, low toxicity, powdery mildew had to the advantages such as special efficacy, be suitable for ornamental plants, the field crops such as fruit tree, vegetables, flowers.For preventing and treating various powdery mildews, as apple, grape, cucumber, strawberry, rose, sweet Lay powdery mildew.The bupirimate chemistry is by name: 5-butyl-2-ethylamino-6-methylpyrimidine-4-base dimethylamino sulfuric ester, its chemical structural formula is
Using chemical agent is the most effectively means of controlling plant diseases.But long-term use single chemical bactericide continuously high dose, easily cause the problems such as residual, the environmental pollution of medicament and anti-pesticide resistance fungi development.Reasonably chemical bactericide is composite or be mixed and have the expansion fungicidal spectrum, improve control efficiency, extend the optimum period for applying fertilizer, reduce dosage, reduce poisoning, reduce residual, delay Antifungal resistance and the positive characteristics such as drug-fast generation and development, bactericide compounded is one of the effective method the most addressed the above problem.Exploitation new product bactericide price is constantly soaring, and by contrast, exploitation is efficient with research, low toxicity, low-residual composite be mixed there is small investment, the lead time is short and be subject to domestic and international attention, the numerous and confused dynamics that develops that strengthens.We filter out oxime bacterium ester and bupirimate and carry out compositely on the basis of lab screening and field trial, have obvious synergistic effect.And there is no at present the people about the composite bactericidal composition of oxime bacterium ester and bupirimate and application reported.
Summary of the invention
Based on above situation, the object of the invention is to provide a kind of new and effective pesticide sterilizing composite.Nearly all Mycophytes (Ascomycetes, Basidiomycetes, Oomycete and Fungi Imperfecti) disease is all had to good activity as powdery mildew, rust, Ying's rot, net blotch, downy mildew, rice blast etc.Damping off, apple apple scab are also had to good activity.
Technical scheme of the present invention realizes by following measures:
A kind of bactericidal composition that contains oxime bacterium ester and bupirimate, active ingredient oxime bacterium ester and two yuan of the bupirimates of this bactericidal composition are composite, and all the other are auxiliary element.In wherein said bactericidal composition, the mass ratio of active ingredient oxime bacterium ester and bupirimate is 1～40: 40～1, described bactericidal composition of the present invention is through the toxicity test experimental verification, the mass ratio of oxime bacterium ester and bupirimate is 1～40: 40～1 o'clock, and synergistic effect is better.
The formulations of pesticide that described bactericidal composition of the present invention can be prepared are missible oil, suspending agent, wetting powder, water dispersible granules, aqueous emulsion, microemulsion, granule, microcapsule formulations.Wherein active ingredient oxime bacterium ester and the bupirimate gross mass in preparation accounts for 1%～80% of the whole quality of the pharmaceutical preparations, while wherein accounting for 5%～50%, and toxicity and the residual balance preferably that reaches, cost is also lower.
The specific embodiments of the formulations of pesticide that bactericidal composition of the present invention is mixed with is as follows:
Described bactericidal composition is cream preparation, and the mass fraction of component is: 1～40 part of oxime bacterium ester; 1～40 part of bupirimate; 10～30 parts of conventional emulsifiers; 20～50 parts of conventional solvents; 1～5 part of conventional synergist.The concrete production stage of this cream preparation adds emulsifier, the synergist rear oily liquids that becomes transparent and homogeneous that stirs again for first active ingredient oxime bacterium ester and bupirimate being added in solvent after dissolving fully, filling, can be made into the cream preparation of the present composition.
Described bactericidal composition is suspending agent, and the mass fraction of component is: 1～40 part of oxime bacterium ester; 1～40 part of bupirimate; 5～20 parts of dispersants; 1～5 part of antifreezing agent; 0.1～2 part of thickener; 0.1～0.8 part of defoamer; 0～10 part of penetrating agent; 0.1～5 part of pH value conditioning agent; Water, surplus.The concrete production stage of this suspending agent is for first mixing other auxiliary agents, mix through high speed shear, add active ingredient oxime bacterium ester and bupirimate, in ball crusher, abrading-ball is 2～3 hours, make a diameter all below 5mm, can be made into the suspending agent preparation of the present composition.
Described bactericidal composition is wetting powder, and the mass fraction of component is: 1～40 part of oxime bacterium ester; 1～40 part of bupirimate; 3～10 parts of dispersants; 1～5 part of wetting agent; Filler, surplus.The concrete production stage of this wetting powder is: by above-mentioned formula, active ingredient oxime bacterium ester is mixed with bupirimate and dispersant, wetting agent and filler, uniform stirring in stirred tank, mixing after airslide disintegrating mill, can be made into the wetting powder of the present composition.
Described bactericidal composition is water dispersible granules, and the mass fraction of component is: 1～40 part of oxime bacterium ester; 1～40 part of bupirimate; 3～10 parts of dispersants; 1～10 part of wetting agent; 1～5 part of disintegrant; Filler, surplus.The concrete production stage of this water dispersible granules is: by above-mentioned formula, active ingredient oxime bacterium ester is mixed with bupirimate and dispersant, wetting agent, disintegrant and filler, with micro jet, pulverize, through mediating, then add in the fluidized bed prilling dryer and carry out granulation, drying, screening by sample analysis, can be made into the water dispersible granules of the present composition.
Described bactericidal composition is aqueous emulsion, and the mass fraction of component is: 1～40 part of oxime bacterium ester; 1～40 part of bupirimate; 3～30 parts of emulsifier; 5～15 parts of solvents; 2～15 parts of stabilizing agents; 1～5 part of antifreezing agent; 0.1～8 part of defoamer; 0.2～2 part of thickener; Water, surplus.The concrete production stage of this aqueous emulsion is: at first oxime bacterium ester and bupirimate, solvent and emulsifier, cosolvent are added together, make to be dissolved into uniform oil phase; By part water, antifreeze, other the insecticides adjuvant such as antimicrobial mixes into uniform water; When the reactor high speed stirs, oil phase is added to water, slowly add water until reach the phase inversion point, open clipper and carry out high speed shear, and add remaining water, shear about half an hour, form the aqueous emulsion of oil-in-water type, can be made into the aqueous emulsion of the present composition.
Described bactericidal composition is microemulsion, and the mass fraction of component is: 1～40 part of oxime bacterium ester; 1～40 part of bupirimate; 10～30 parts of emulsifier, 1～8 part of antifreezing agent, 0.5～10 part of stabilizing agent, 20～50 parts of conventional solvent cosolvents.Oxime bacterium ester and bupirimate are dissolved fully with cosolvent, then add other compositions such as emulsifier, antifreezing agent stabilizing agent, evenly mix, finally add water, after fully stirring, can be made into microemulsion.
Described bactericidal composition is granule, and the mass fraction of component is: 1～40 part of oxime bacterium ester; 1～40 part of bupirimate; 1～10 part of wetting dispersing agent; 0.1～5 part of thickener; 0.1～5 part of defoamer; Castor oil, surplus is supplied.Active ingredient oxime bacterium ester is mixed in the ratio of formula with each components such as bupirimate, dispersant, stabilizing agent, defoamer and solvents, after putting into the grinding of sand milling still, send in mixer for well-distribution and mix and get product.
Described bactericidal composition is microcapsule formulations, and the mass fraction of component is: 1～40 part of oxime bacterium ester; 1～40 part of bupirimate; 5～20 parts, urea; 5～20 parts, formaldehyde; 5～20 parts of emulsifying dispersants; 1～5 part of antifreezing agent; 0.1～2 part of thickener; 0.1～0.8 part of defoamer; Water, surplus.In being housed, the there-necked flask of agitating device adds urea and formaldehyde (the amount of substance ratio is about l:1.5～2.0), with the pH value to 8 of sodium hydroxide solution regulator solution～9 left and right, then be warming up to 70～80 ℃, reaction obtains stable urea resin prepolymer.The former medicine of getting a certain amount of oxime bacterium ester and bupirimate is dissolved in cyclohexane, and adds emulsifying dispersant in solution, follows vigorous stirring, the O/W type stable emulsion that to be made into the aqueous solution of take containing emulsifying dispersant be water.Above-mentioned urea resin prepolymer is added in emulsion, regulate the pH value, polymerization reaction take place under the acid catalysis condition, be wrapped oil phase substance, forms microcapsule granule.Slowly heat up, solidify, temperature is controlled at 40～50 ℃, hardening time 1h.Selection adds appropriate auxiliary agent, the microcapsule suspending agent that gets final product stablely.
Wherein above-described emulsifier is selected from calcium dodecyl benzene sulfonate and aliphatic acid polyethenoxy ether, the alkylphenol polyoxyethylene sulfosuccinate, styrylphenol polyoxyethylene ether, polyoxyethylene nonylphenol ether, castor oil polyoxyethylene ether, aliphatic acid polyethenoxy base ester, any or more than one any mixtures than forming in polyoxyethylene aliphatic alcohol ether.
Described solvent is dimethylbenzene or biodiesel, toluene, and diesel oil, methyl alcohol, ethanol, n-butanol, isopropyl alcohol, turpentine oil, solvent naphtha, dimethyl formamide, dimethyl sulfoxide (DMSO), one or more in the water equal solvent are arbitrarily than the mixture formed.
Described dispersant is selected from polycarboxylate, lignosulfonates, alkylphenol polyoxyethylene methyl ether condensate sulfate, the alkylsulfonate calcium salt, the naphthalene sulfonic acid-formaldehyde condensation product sodium salt, alkylphenol polyoxyethylene, polyoxyethylene carboxylate, aliphatic amine polyoxyethylene ether, one or more in the fatty acid glyceride APEO.
Described wetting agent is selected from lauryl sodium sulfate, calcium dodecyl benzene sulfonate, and Nekal BX, moistening bleeding agent F, alkylbenzenesulfonate polyoxyethylene triphen is phosphenylic acid salt dimly, spaonin powder, silkworm excrement, one or more in the soapberry powder.
Described disintegrant is selected from bentonite, urea, ammonium sulfate, aluminium chloride, citric acid, succinic acid, one or more in sodium bicarbonate.
Described thickener is selected from xanthans, carboxymethyl cellulose, carboxyethyl cellulose, methylcellulose, Magnesiumaluminumsilicate, in polyvinyl alcohol one or more.
Described stabilizing agent is selected from sodium citrate, a kind of in resorcinol.
Described antifreezing agent is selected from ethylene glycol, propane diols, one or more in glycerine.
Described defoamer is selected from silicone oil, silicone compound, C
10-20the saturated fat acid compounds, C
8-10one or more of fatty alcohol.
Described filler is selected from kaolin, diatomite, bentonite, attapulgite, white carbon, starch, one or more in precipitated calcium carbonate.
The present invention be take the composite bactericide that oxime bacterium ester and bupirimate be active ingredient and is had obvious synergistic effect, delays the drug-fast generation in key, and has reduced to become to produce cost and use cost, can be used for the improvement of resistance disease.Nearly all Mycophytes (Ascomycetes, Basidiomycetes, Oomycete and Fungi Imperfecti) disease, as powdery mildew, rust, Ying's rot, net blotch, downy mildew, rice blast etc. all have good activity, is also had to good activity to damping off, apple apple scab.
Embodiment
For making technical scheme of the present invention, purpose and advantage are clearer, and the present invention describes with following specific embodiment, but the present invention is not limited to these examples.The mode that effect experiment of the present invention adopts indoor biometrics and field trial to combine, if no special instructions, the ratio of below mentioning is all ratio of quality and the number of copies.
Embodiment: oxime bacterium ester proportioning co-toxicity experiments different from bupirimate.
1.1 reagent agent
The former medicine of 95% oxime bacterium ester, the former medicine of 95% bupirimate, above-mentioned former medicine provides by research and development department of extra large rel medicine company limited company.
1.2 test target
Never executed oxime bacterium ester and bupirimate from Shouguang, Shandong and cucumber of the same type gathers and separates potted plantly, for the examination cucumber variety: Chang Chun Mi Ci.
1.3 test method
1.3.1 medicament preparation
First use the former medicine of acetone solution, according to the result of preliminary experiment, two appropriate former medicines are made into to different proportionings, then it is stand-by with acetone, each processing to be diluted to respectively to some concentration gradients.
Susceptible cucumber variety Chang Chun Mi Ci cultivation, in pot for growing seedlings, is placed in to greenhouse and cultivates, and plant grows to three to four leaf after dates, gathers the blade of identical leaf age, for cultivation and the mensuration of powdery mildew of cucumber bacterium.
1.3.2 the cultivation of powdery mildew of cucumber bacterium and the preparation of spore suspension
The powdery mildew of cucumber bacterium adopts the plants method to cultivate under 20 ℃, the condition of 12h alternation of light and darkness, and every 30 d turn culture 1 time.During inoculation, with the conidium on sterile water wash-out incidence of leaf, being mixed with spore concentration is l * 10
6the suspension of individual/mL.
1.3.3 strains tested sensitivity testing
Adopt leaf dish moisturizing method to carry out toxicity test.First the blade of collection is prepared into to the leaf dish that diameter is 1.5cm, mix at random, be placed in respectively the series concentration liquid configured and soak lh, 50 leaf dishes of each concentration, test is with the blank that is treated to of adding medicine not, after soaking end, leaf faces up and puts on the blotting paper wetting in identical liquor strength, liquid on the leaf dish is blotted, the spore suspension l0L prepared is inoculated in to leaf dish central authorities, after room temperature is placed 5 min, is placed under 20 ℃, the condition of 1 2h alternation of light and darkness and cultivates, measure the onset area on the leaf dish after 10d, calculate EC
50.
On the basis of preliminary experiment, respectively single dose oxime bacterium ester and bupirimate are carried out to toxicity test in order to upper method, the two EC
50value is respectively 4.73 ㎎/l and 14.32 ㎎/l.
The percentage that accounts for the leaf disc area according to lesion area is divided sick level
0 grade: anosis;
1 grade: the sorus area accounts for below 5% of whole leaf area;
3 grades: the sorus area accounts for below the 6%-10% of whole leaf area;
5 grades: the sorus area accounts for below the 11%-20% of whole leaf area;
7 grades: the sorus area accounts for below the 21%-50% of whole leaf area;
9 grades: the sorus area accounts for more than 50% of whole leaf area.
1.3.4 mixture toxicity test and interpretation of result
Carry out the toxicity test of mixture according to mixed ratio by single dose toxicity test method.
If contrast lethality<5%, do not proofread and correct, the contrast lethality, between 5%-20%, is proofreaied and correct by formula 2, the contrast lethality > 20%, test need be reformed.
The logarithm value of drug concentration (mg/L) of take is independent variable x, and the probability value of corrected mortality of take is dependent variable y, sets up respectively the virulence regression equation formula, adopts DPS software to calculate the EC of single dose and each proportioning mixture
50calculate co-toxicity coefficient (CTC) according to the abundant method of Sun Yun.Co-toxicity coefficient CTC, computing formula is as follows: (take 2-cyano-3-amino-3-phenylancryic acetate as the standard medicament, its toxicity index is 100):
The EC of the toxicity index of bupirimate (TI)=oxime bacterium ester
50the EC of/bupirimate
50* 100
The EC of the true toxicity index (ATI) of M=oxime bacterium ester
50the EC of/M
50* 100
The TI of the TI of the theoretical toxicity index (TTI) of M=oxime bacterium ester * P oxime bacterium ester+bupirimate * P bupirimate
The TTI of the ATI/M of the co-toxicity coefficient of M (CTC)=M * 100
In formula:
M is oxime bacterium ester and the mixture of the different proportionings of bupirimate
P oxime bacterium ester is oxime bacterium ester shared ratio in mixture
The P bupirimate is bupirimate shared ratio in mixture.
2.1 toxicity test result
Table 1 oxime bacterium ester and the bupirimate toxicity test to powdery mildew of cucumber
As can be seen from the table, the result of the test of different proportion proportioning shows, dilute respectively and all show stronger synergistic effect in the active ingredient ratio, wherein take oxime bacterium ester and bupirimate as 1:20～20:1 the time the good suggestion of synergistic effect suitable proportion 1:20～20:1 left and right mixture preparation is carried out to further field control effectiveness test, to estimate its field practical application effect.
3 field trials are prevented and treated the experimental result of powdery mildew of cucumber, rice sheath blight disease
3.1 field trial is prevented and treated powdery mildew of cucumber
3.1.1 test method
Test is at 4 points of Pingdu City cucumber Di，Mei community, Shandong investigation, and every some investigation 2 strains, put down in writing occurring degree by staging, and grade scale is as follows:
0 grade: anosis;
1 grade: the sorus area accounts for below 5% of whole leaf area;
3 grades: the sorus area accounts for below the 6%-10% of whole leaf area;
5 grades: the sorus area accounts for below the 11%-20% of whole leaf area;
7 grades: the sorus area accounts for below the 21%-50% of whole leaf area;
9 grades: the sorus area accounts for more than 50% of whole leaf area.
3.1.2 control time and number of times
Test is investigated 4 times altogether, and radix investigation before medicine is investigated after 10 days, 10 days for the second time and medicine after medicine for the first time in 21 days.
3.1.3 drug effect computational methods
Sick leaf rate (%)=sick number of sheets/investigate total number of sheets * 100
Disease index=∑ (the sick numbers of sheets at different levels * relative level numerical value)/(investigating total number of sheets * 9) * 100
Control efficiency (%)=(disease index after disease index before 1-(blank district medicine * treatment region medicine)/(disease index before disease index after blank district medicine * treatment region medicine)) * 100.
3.1.4 poisoning investigation method
After dispenser, whether continuous 10d range estimation medicament has poisoning to crop.
3.1.5 result of the test and analysis
Each processes the effect of preventing and treating powdery mildew of cucumber.(table 2)
Each processes the effect of preventing and treating powdery mildew of cucumber table 2
As shown in Table 2 oxime bacterium ester and bupirimate with 12:36 ratio composite bactericide for powdery mildew of cucumber control successful higher than oxime bacterium ester and bupirimate single dose, bactericidal effect increases progressively with the increase of dosage.According to the field range estimation, in the test dose scope, plant growth is normal, and the poisoning phenomenon to cucumber does not all appear in each treatment agent, illustrates that it is safe to cucumber.Advise that the bactericide different from the mechanism of action mixes use to delay the drug-fast generation of germ.
3.2 field trial is prevented and treated rice sheath blight disease
3.2.1 test method
Rice seedling is transplanted in test in Lian Feng village, Liu Bao town, Baoying County, soil property is sandy soil, pH value 8, and the content of organic matter 2.0, fertility is general, front stubble wheat.For the examination paddy rice, be Huaihe River rice No. 5, June 19 transplanted, and growing way is better, and during medication, be booting stage breeding time, and the field water rice sheath blight occurs heavier.
3.2.2 control time and number of times
Test is investigated 4 times altogether, takes 20 clumps of rice of parallel great-jump-forward sampling ，Mei community investigation, record diseased plant number, sick level, and statistics diseased plant rate and disease index, radix investigation before medicine, investigated after 10 days, 10 days for the second time and medicine after medicine for the first time in 21 days.
Put down in writing occurring degree by staging, grade scale is as follows:
0 grade: complete stool is anosis;
1 grade: quaterfoil and following each leaf sheath thereof, blade morbidity (take top as the first blade);
3 grades: the 3rd blade and following each leaf sheath thereof, blade morbidity;
5 grades: the second blade and following each leaf sheath thereof, blade morbidity;
7 grades: sword-like leave blade and following each leaf sheath thereof, blade morbidity;
9 grades: the complete stool morbidity, withered ahead of time.
3.2.3 drug effect computational methods
Diseased plant rate (%)=diseased plant number/investigate total strain number * 100
Disease index=∑ (diseased plant numbers at different levels * relative level numerical value)/(investigating total strain number * 9) * 100
Control efficiency (%)=(disease index after disease index before 1-(blank district medicine * treatment region medicine)/(disease index before disease index after blank district medicine * treatment region medicine)) * 100.
3.2.4 poisoning investigation method
After dispenser, whether continuous 10d range estimation medicament has poisoning to crop.
3.2.5 result of the test and analysis
Each processes the effect of preventing and treating rice sheath blight disease table 3
Interpretation of result:
As shown in Table 3, oxime bacterium ester and bupirimate are more remarkable with the effect of 12:36 ratio compositional bactericidal agent for preventing and treating rice sheath blight disease, and the effect of complex preparation significantly is better than two kinds of single doses, according to field, estimate, in the test dose scope, plant growth is normal, and the poisoning phenomenon to paddy rice does not all appear in each treatment agent, not only significantly improve the effect for rice sheath blight disease, and further extended its lasting period.
In sum, the Bactericidal composite that the present invention contains oxime bacterium ester and bupirimate, have good control efficiency to powdery mildew of cucumber, rice sheath blight disease, and it is to the target crop safety.Complex preparation has not only improved preventive effect, and has enlarged fungicidal spectrum, widens the scope of application, reduces costs, and multiple diseases is played to the double effect of controlling of a medicine, alleviates manpower and materials, improves productivity effect.So the invention of this complex preparation is of great significance social tool with popularization.
Claims (4)
1. a bactericidal composition that contains oxime bacterium ester and bupirimate, it is characterized in that: the active ingredient of this bactericidal composition is oxime bacterium ester and bupirimate binary built, all the other are auxiliary element, and wherein the mass ratio of active ingredient oxime bacterium ester and bupirimate is 1～40: 40～1.
2. bactericidal composition according to claim 1, it is characterized in that: oxime bacterium ester and the bupirimate gross weight in preparation accounts for 1%～80% of the whole quality of the pharmaceutical preparations.
3. bactericidal composition according to claim 2, it is characterized in that: oxime bacterium ester and the bupirimate gross weight in preparation accounts for 5%～50% of the whole quality of the pharmaceutical preparations.
4. according to claim 1 or 2 or 3 described bactericidal compositions, it is characterized in that: the formulation of this bactericidal composition is missible oil, suspending agent, wetting powder, water dispersible granules, aqueous emulsion, microemulsion, granule, microcapsule formulations
.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101684545A CN103229767A (en) | 2013-05-09 | 2013-05-09 | Trifloxystrobin and bupirimate-containing sterilization composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013101684545A CN103229767A (en) | 2013-05-09 | 2013-05-09 | Trifloxystrobin and bupirimate-containing sterilization composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103229767A true CN103229767A (en) | 2013-08-07 |
Family
ID=48877904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013101684545A Pending CN103229767A (en) | 2013-05-09 | 2013-05-09 | Trifloxystrobin and bupirimate-containing sterilization composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103229767A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105248422A (en) * | 2015-11-18 | 2016-01-20 | 青岛瀚生生物科技股份有限公司 | Anti-fungal composition containing amylmetacresol methyl ether and trifloxystrobin and application thereof |
| CN105360119A (en) * | 2015-12-19 | 2016-03-02 | 青岛奥迪斯生物科技有限公司 | Sterilization composition containing trifloxystrobin and efficient metalaxyl-M |
| CN105475288A (en) * | 2016-01-16 | 2016-04-13 | 海南正业中农高科股份有限公司 | Bactericidal composition containing trifloxystrobin and ethirimol |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002069715A2 (en) * | 2001-03-06 | 2002-09-12 | Bayer Cropscience Ag | Seed dressing agent |
| CN101595883A (en) * | 2009-05-07 | 2009-12-09 | 深圳诺普信农化股份有限公司 | A kind of composition pesticide and application thereof |
| CN102308825A (en) * | 2011-10-13 | 2012-01-11 | 海利尔药业集团股份有限公司 | Germicide composition in combination with bupirimate |
-
2013
- 2013-05-09 CN CN2013101684545A patent/CN103229767A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002069715A2 (en) * | 2001-03-06 | 2002-09-12 | Bayer Cropscience Ag | Seed dressing agent |
| CN101595883A (en) * | 2009-05-07 | 2009-12-09 | 深圳诺普信农化股份有限公司 | A kind of composition pesticide and application thereof |
| CN102308825A (en) * | 2011-10-13 | 2012-01-11 | 海利尔药业集团股份有限公司 | Germicide composition in combination with bupirimate |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105248422A (en) * | 2015-11-18 | 2016-01-20 | 青岛瀚生生物科技股份有限公司 | Anti-fungal composition containing amylmetacresol methyl ether and trifloxystrobin and application thereof |
| CN105360119A (en) * | 2015-12-19 | 2016-03-02 | 青岛奥迪斯生物科技有限公司 | Sterilization composition containing trifloxystrobin and efficient metalaxyl-M |
| CN105475288A (en) * | 2016-01-16 | 2016-04-13 | 海南正业中农高科股份有限公司 | Bactericidal composition containing trifloxystrobin and ethirimol |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103271031A (en) | Sterilization composition containing cyanoacrylate bactericide and metalaxyl-M | |
| CN103355333A (en) | Sterilization composition containing pyraclostrobin and boscalid | |
| CN105409990A (en) | Sterilization composition containing pyraclostrobin and efficient metalaxyl-M | |
| CN103168780A (en) | Bactericidal composition containing fluopicolide and metrafenone | |
| CN103719102A (en) | Sterilization composite containing fluopyram and prothioconazole | |
| CN103355308A (en) | Sterilization composition containing prothioconazole and boscalid | |
| CN103081913A (en) | Sterilization composition containing boscalid and kresoxim-methyl | |
| CN103125494A (en) | Bactericidal composition containing (E,E,E)-N-methyl-2-[((((1-methyl-3-(2,6-dichlorophenyl)-2-propenyl)imino)oxy)methyl)phenyl]-2-methoxyiminoacetamide and penthiopyrad | |
| CN103229767A (en) | Trifloxystrobin and bupirimate-containing sterilization composition | |
| CN105409976A (en) | Sterilization composition containing efficient metalaxyl-M and flumorph | |
| CN103918694A (en) | Bactericidal composition containing iprodione and metalaxyl-M | |
| CN103141493A (en) | Bactericidal composition containing difenoconazole and benthiavalicarb-isopropyl | |
| CN103392726B (en) | A kind of bactericidal composition that contains iprodione and prothioconazoles | |
| CN103688938A (en) | Bactericidal composition containing fluopyram and bupirimate | |
| CN103503879A (en) | Sterilization composition containing prothioconazole and bupirimate | |
| CN103975928A (en) | Bactericidal composition containing meptyldinocap and penconazole | |
| CN103783046A (en) | Fungicidal composition containing prothioconazole and pyrimethanil | |
| CN103688951A (en) | Bactericidal composition containing fluopyram and pyrisoxazole | |
| CN103300009A (en) | Sterilization composition with coumoxystrobin and penconazole | |
| CN105104386A (en) | Sterilization composition containing hymexazol and fludioxonil | |
| CN103300015A (en) | Sterilizing composition comprising boscalid and pyrisoxazole | |
| CN104757005A (en) | Fungicide composition containing metalaxyl and thifluzamide | |
| CN103688939A (en) | Bactericidal composition containing fluopyram and ethirimol | |
| CN104126593A (en) | Sterilization composition containing ametoctradin and fluopyram | |
| CN103688937A (en) | Bactericidal composition containing fluopyram and triflumizole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130807 |